Sign up for smart news, insights, and analysis on the biggest financial stories of the day
The LEADER trial 28 (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) studied a 1.8-mg dose in more than 9,000 patients with type 2 diabetes and found the incidence of acute pancreatitis was similar between the liraglutide and placebo groups (0.4% vs 0.5%, respectively)
14 A 2017 meta-analysis of 52 randomized, controlled trials that evaluated DPP-4 inhibitors' effects on beta-cell function found that, in monotherapy studies, all agents except linagliptin resulted in improvements in cell function
Currently, only Wegovy and Saxenda are However, researchers show there is a growing number of people without diabetes The amount of weight a person may lose on a GLP-1 agonist varies
DM, diabetes mellitus
A 2500 mcg dosage represents a high-potency therapeutic intervention designed to rapidly elevate serum B12 levels